Nevertheless, there are few studies exploring the DDR gene mutational characteristics and their correlation with outcomes to platinum-based chemotherapy and platinum-based chemotherapy/immunotherapy in NSCLC without EGFR and ALK alterations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.